IL22 and colitis: Thus, the role of IL-22 in the context of chronic inflammation during IBD needs to be carefully re-evaluated, and the supplementation of exogenous IL-22, especially in an Fc fusion with long serum half-life, to patients with active colitis should be re-considered with extreme caution.